Skip to content

Spray Skin Treats for Pediatric Burns

Spray Skin Treats in the Treatment of Pediatric Burns

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06182345
Enrollment
100
Registered
2023-12-26
Start date
2012-01-01
Completion date
2024-12-31
Last updated
2024-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Burn

Keywords

Pediatric burn, Spray skin, skin graft

Brief summary

The treatment of burns in children remains a global challenge. At present, the clinical treatment plan is still waiting for further improvement. This study intends to retrospectively analyze the experience of treating children burn in recent years and promote sharing and application.

Detailed description

The treatment of burns in children remains a global challenge. Children's burn wounds have many characteristics that are different from those of adults, such as easy deepening of the wound, uncooperation in dressing change, poor resistance and so on. At present, there are new dressing applications a nd surgery in clinical treatment, etc., but how to treat children to achieve better therapeutic effects still needs to be explored. This study intends to retrospectively analyze the experience of treating children burn in recent years and promote sharing and application.

Interventions

PROCEDUREspray skin

autologous skin cell suspension combined with skin graft

PROCEDUREskin graft

skin graft

Sponsors

First Affiliated Hospital, Sun Yat-Sen University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* burn for any reasons * Children

Exclusion criteria

* Combined with mental illness * Congenital immune disease * Severe cardiopulmonary failure,etc

Design outcomes

Primary

MeasureTime frameDescription
take ratepostoperative day 4 weekstake rate of skin graft

Secondary

MeasureTime frameDescription
complication ratethrough study completion, an average of 6 monthsafter skin grafting, skin infection, necrosis, subcutaneous hematoma, etc

Countries

China

Contacts

Primary ContactZhicheng Hu
willway128@163.com02087338235
Backup ContactShushan Huang
zsyyiec2020@mail.sysu.edu.cn02087330631

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026